Yarina Rangel

Yarina Rangel

Auto-generated profile, based on publicly available information

Yarina Rangel

Univ Fed Rio De Janeiro UFRJ, Inst Puericultura & Pediat Martagao Gesteira, Rua Bruno Lobo 50, Rio De Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2024 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
GLGiuliana Pucarelli Lebreiro
Giuliana Pucarelli Lebreiro
MVMarianna Tavares Venceslau
Marianna Tavares Venceslau
MGMaria Angelica Arpon Marandino Guimarães
Maria Angelica Arpon Marandino Guimarães
TAThalita Fernandes Abreu
Thalita Fernandes Abreu
YRYarina Rangel
Yarina Rangel
CHCristina Hofer
Cristina Hofer
Objective: In order to study the scenario of respiratory infections in pediatrics after the emergence of SARS-CoV-2 in Brazil, this study aimed to compare characteristics of children admitted for SARS or upper airway infection caused by either RSV or SARS-CoV-2. Methods: This was a cross-sectional study involving children up to 48 months of age admitted to a tertiary pediatric hospital with a diagnosis of SARS or upper airway infection between April of 2020 and April of 2021. Respiratory secretion samples were collected 2-5 days after hospitalization, and antigen/PCR tests for viral etiologies were performed. In this analysis, patients with laboratorial diagnosis of SARS-CoV-2 and/or RSV were selected, and their clinical and epidemiological characteristics were compared using logistic regression. Results: Our sample initially comprised 369 participants. SARS-CoV-2 and RSV infections were confirmed in 55 (15%) and 59 children (16%), respectively. Mean age was 12 months (0-48 months), and 47 were female. The following characteristics were significantly more frequent in patients with RSV when compared with those with COVID-19: younger age (OR = 0.94; 95% CI: 0.90-0.98); lower frequency of fever (OR = 0.18; 95% CI: 0.05-0.66); and more frequent upper airway symptoms: cough (OR = 7.36; 95% CI: 1.04-52.25); and tachypnea (OR = 6.06; 95% CI: 1.31-28.0). Conclusions: Children with RSV-related SARS were younger, had lower frequency of fever at admission, but had a higher frequency of signs of upper airway infection and lower systemic inflammation when compared with children hospitalized for COVID-19 during the first year of the pandemic.